Company Filing History:
3 out of 343 
1 out of 15 Years Active: 2010-2012
Title: **The Innovative Contributions of Paolo Ghetti**
Introduction
Paolo Ghetti, a notable inventor hailing from Rodano, Italy, has made significant strides in the field of pharmaceuticals. With four patents to his name, Ghetti has focused on developing advanced crystalline forms of essential compounds, contributing to the efficiency and effectiveness of medical treatments.
Latest Patents
Among his latest innovations is the patent for crystalline irinotecan hydrochloride and methods for its preparation. This invention presents a crystalline form of irinotecan hydrochloride that is particularly suitable for industrial applications, offering advantages such as easy filtration, high stability, and purity. Additionally, Ghetti has developed a stereoselective process for preparing 7-[(E)-t-butyloxyiminomethyl]-camptothecin, also known as gimatecan. This process not only enhances the preparation method but also results in four new crystalline forms of gimatecan, thereby expanding the potential for its applications in the pharmaceutical arena.
Career Highlights
Throughout his career, Paolo Ghetti has collaborated with esteemed companies in the pharmaceutical industry, such as Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. and Antibioticos S.p.A. His work in these organizations has furthered his research and culminated in impactful innovations that address current medical needs.
Collaborations
In addition to his individual contributions, Ghetti has worked alongside distinguished colleagues, including Marco Alpegiani and Paolo Carminati. These collaborations have not only enhanced the quality of his work but also fostered a culture of innovation and progression within the field.
Conclusion
Paolo Ghetti’s dedication to innovation in pharmaceuticals has established him as a respected inventor in the industry. Through his patents and collaborative efforts, he continues to shape the future of medical treatments, ensuring that advancements in technology and chemistry translate into tangible benefits for patient care.